The Board of Regents of the University of Texas System v. Alnylam Pharmaceuticals Inc. et al
Case Summary
The Board of Regents of the University of Texas System v. Alnylam Pharmaceuticals Inc. et al is a civil case with an unknown court. The case was filed under docket number 25-cv-13865. The plaintiff, The Board of Regents of the University of Texas System, is suing Alnylam Pharmaceuticals Inc. et al for unspecified reasons. The case is ongoing.
No timeline activity recorded yet. This page will grow as rulings and filings land.
Key Issues
- • plaintiff
- • defendants
- • court
- • docket number
Docket Snapshot
Court
D. Mass.
District of Massachusetts · 1st Circuit · MA
Docket
Not captured
Civil
Stage
Active litigation
Active
Filed
Date unavailable
Not in the available feed
Latest Filing
1:25-cv-13865 The Board of Regents of the University of Texas System v. Alnylam Pharmaceuticals Inc. et al
Other · Apr 23, 2026
Coverage
1 article
1 source tracked
Participants
1 Defendant, 1 Plaintiff
3 linked entities
Judge
Not assigned in feed
What the record shows
This case is tied to District of Massachusetts, a federal district court in MA.
The newest docket activity we have is a other dated April 23, 2026.
The visible party/entity graph currently includes Alnylam Pharmaceuticals Inc, 1:25-cv-13865 The Board of Regents of the University of Texas System and others.
Press monitoring has found 1 related article from 1 distinct source.
The Story So Far
The Board of Regents of the University of Texas System v. Alnylam Pharmaceuticals Inc. et al is an active civil matter in District of Massachusetts under docket 25-cv-13865.
The dispute currently identifies 1:25-cv-13865 The Board of Regents of the University of Texas System on one side and Alnylam Pharmaceuticals Inc on the other. The case is currently organized around defendants, docket number.
et al is a civil case with an unknown court. The case was filed under docket number 25-cv-13865. The plaintiff, The Board of Regents of the University of Texas System, is suing Alnylam Pharmaceuticals Inc.
et al for unspecified reasons. The case is ongoing.
On April 23, 2026, the docket recorded a other: The University of Texas System sued Alnylam Pharmaceuticals and other defendants for allegedly infringing on a patent related to RNA interference technology. The lawsuit seeks damages and an injunction to stop the defendants from using the technology. This.
The next thing to watch is whether the latest other produces a substantive order, a scheduling change, a settlement signal, or a filing that clarifies the parties' positions.
About This Court
District of Massachusetts (D. Mass.) is a federal district court in the 1st Circuit, MA.
Case Timeline
1 event1:25-cv-13865 The Board of Regents of the University of Texas System v. Alnylam Pharmaceuticals Inc. et al
The University of Texas System sued Alnylam Pharmaceuticals and other defendants for allegedly infringing on a patent related to RNA interference technology. The lawsuit seeks damages and an injunction to stop the defendants from using the technology. This case is significant because it involves a high-stakes patent dispute in the biotechnology industry.
Press Coverage
settings_backup_restore Data provenance expand_more
Sources tracked
1 outlet · 1 article
Timeline events
1 record on file
Last updated
1 day, 18 hours ago
Juryvine aggregates docket entries from PACER/CourtListener, press coverage, and GDELT signals. Ingestion timestamps do not appear in the What Changed feed — that reflects real court activity only.